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Introduction 
Glioma is a prevalent central nervous system (CNS) 
tumor, involving 80% of all malignant brain tumors and 
30% of all CNS tumors,1 and it comes in a variety of 
malignancy grades and histological subtypes.2 Glioma 
is the prevalent cause of death from main brain tumors, 
and it is also a particularly deadly cancer worldwide. 
Glioblastoma multiforme (GBM), the highly widespread 
and aggressive glioma, has a median total survival rate of 
about 15 months that has stayed constant for decades.3 
Gliomas are primary brain tumors believed to be 
caused by neuroglial stem or progenitor cells. Rapid cell 
proliferation and angiogenesis are hallmarks of gliomas.4
Non-coding RNAs (ncRNAs) have been shown to affect 
biological processes that control glioma progression 
and initiation in a number of studies.5 Circular RNAs 
(circRNAs) are circular single-stranded RNA molecules 
that do not have 5′ caps and a 3′ poly A tails. CircRNAs 
are formed by back-splicing from precursor mRNA 
(pre-mRNA), where an upstream acceptor site is linked 
to a donor site.6 CircRNAs are resistant to exonucleases, 
including RNase R, and have a longer half-life than linear 
mRNAs.7-9 CircRNAs have a stable and conserved closed-
loop structure and have different degrees of expression 
in different organs and tissues of the body and play an 
important role in the onset and progression of diseases 
such as cancer through different pathways.10
CircRNA has a covalent closed-loop structure and is 
an extremely stable and conservative special RNA that 
is commonly distributed in different tissues and organs 
with varying expression degrees and plays a role in the 
prevalence and progression of diseases such as cancer 
in a variety of ways.10 A large study of more than 2000 
different cancer samples showed that circRNAs affect 
the pathogenesis of many cancers.11 CircRNAs are often 
involved in various oncogenic processes11-13 because of 
their dysregulation in multiple cancers. CircRNAs affect 
tumor development, metastasis therapy resistance, and 
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EMT transformation.14 Rybak-Wolf et al15 discovered 
that circRNAs are plentiful and unique in neural and 
brain tissues, implying that they affect neural separation 
and neurological disorders. It has also been reported 
that circRNAs can cross the blood-brain barrier through 
exosomes and are present in cerebrospinal fluid (CSF).16 
CSF, produced by choroid plexuses,17 is in direct contact 
with the extracellular fluid of the brain and has a variety of 
functions, including mechanical and chemical protection 
of the brain, nutrient transfer and biological substances, 
and removal of toxic metabolites.18-20 Therefore, the study 
of the presence of circRNAs in CSF can be considered 
as an important ideal biomarker for the diagnosis and 
control of some types of brain tumors.16 Multiple recent 
experiments have revealed that circRNAs are highly 
abundant in neural tissues than other tissues, and that 
they have differential expression patterns in various brain 
regions. This may be due to the proliferation of protein-
coding genes that produce numerous circRNAs, as well 
as splicing factors and RNA-binding proteins (RBPs) 
that regulate circRNA formation.21 Brain-specific genes 
can acquire further sequence properties that foster RNA 
circularization, and broad cis-element and trans-factor 
regulation may lead to a higher abundance of circRNAs in 
the brain.21,22 CircRNAs in glioma specimens, on the other 
hand, are lower than in normal samples,12 this suggests 
that circRNAs may have different roles and functions in 
the development of glioma.
Understanding the role and circRNAs mechanism in 
glioma/GMB tumorigenesis could lead to the creation 
of new tracing procedures and useful treatment steps. In 
this study, current advances in the biological functions 
and molecular mechanisms of circRNAs and the peptides 
encoded by them in glioma/GMB tumorigenesis were 
reviewed. In the following, the clinical association of 
circRNAs with glioma/GMB and their expression level 
and regulatory mechanisms and their role as oncogenes 
or suppressors of tumor in tumorigenesis are discussed. 
Moreover, the potential of circRNAs as diagnostic 
biomarkers and predictors of brain cancer risk and 
possible therapeutic targets in medicine are explored.
Functions of cirRNAs
CircRNAs with enzyme and substrate binding sites can 
serve as protein scaffolding to mediate protein-protein 
interactions. CircRNAs are also involved in transcription, 
translation and alternative splicing of genes, interaction 
with RBP, and cell autophagy; hence, they affect the 
biological function of cancer23-25 (Figure 1).
CircRNAs Act as microRNA Sponges in Glioma
Since many circRNAs have miRNA binding sites 
and miRNA interaction elements, functioning as a 
“miRNA sponge” is the notable significant role and 
process for regulation of human cancer progression and 
growth, especially brain tumors (Figure 2). They affect 
tumorigenesis due to their ability to bind proteins.26 Parts 
of circRNAs with miRNA binding sites have been shown 
to behave as sponges, thus binding and interacting with 
miRNAs and regulating their functions, and influencing 
the expression and activation of target genes, which are 
located downstream of them.27,28 According to Zheng’s 
research, circ-TTBK2 stimulated glioma proliferation 
and prevented apoptosis by serving as a sequence-
specific miR-217 sponge.29 Different miRNAs, like miR-
124-3p and miR-654, may be sponged by circ-HIPK3.30 
Circ-HIPK3 facilitated glioma development via the 
circ-HIPK3/miR-654/IGF2BP3 network.31 MiR-654 was 
established as a circ-HIPK3 target, and miR-654 targeted 
IGF2BP3. Circ-PTN improved Nestin, SOX9, CD133, 
and SOX2 expression by sponging miR-330-5p and miR-
145-5p, promoting glioma development and stemness.32 
Circ_0034642 and circ_0076248 have previously been 
shown to facilitate glioma invasion and proliferation 
in the miR-181a/SIRT1 and miR-1205/BATF3 axis, 
respectively.33,34 CircRNAs could also regulate GMB 
initiation and progression by acting like a “miRNA 
sponge.” CircMMP9, through sponging miR-124 in GBM 
cells, may regulate the eukaryotic initiation factor 4A3 
(eIF4A3) expression, speed up migration, invasion, and 
proliferation.35 Circ_0029426, through sponging miR-
197, promotes cell proliferation and growth, invasion 
and migration while also inhibiting GBM cell apoptosis.36 
According to a recent analysis, circSMARCA5 serves 
as a sponge for the splicing factor serine and arginine 
rich splicing factor 1 (SRSF1), responsible for VEGFA 
expression in GBM.37 CircNT5E acts as a miR-422a 
sponge and influences GBM cell apoptosis, invasion, and 
migration capacity by up-regulating the levels of NT5E, 
Figure 1. Mechanisms and Biological Functions of circRNAs in 
Brain Tumors.
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p-Smad2, PI3KCA, p-Akt and SOX4.38 circRNAMMP9, 
which also spongs miR-124, was found to be up-regulated 
in GBM by Wang et al.35 CiRS-7 (circRNA sponge for miR-
7), as the best known circRNA, was found to be heavily 
expressed in the brain and to have over 70 conserved 
target sites for miR-7.39 CiRS7 overexpression tightly 
bound miR-7, facilitating the unique interaction of miR-
7/AGO2, reducing the CiRS-7 ability to bind and interact 
with target mRNAs. These results appeared to confirm 
that circRNAs acting as miRNA sponges is a prevalent 
occurrence. However, it’s been debated whether miR-
7 and miR-671 shape a regulatory network in the brain 
through sponge function, and whether the ciRS-7 and 
miR-671 combination causes AGO2-mediated cleavage 
of ciRS-7 rather than miR-7 inhibition.40,41 Furthermore, 
many circRNAs had less miRNA binding sites, implying 
that several circRNAs could not act as miRNA sponges. 
As a result, further research is needed to determine the 
impact of circRNAs as miRNA inhibitors or scaffolds. 
CircRNAs Act as Autophagy Regulator in Glioma
Autophagy, as a conserved and sequential process of 
self-destruction, occurs in response to cellular stress 
and survival, and is often involved in tumor progression, 
progression, and metastasis.42,43 CircRNAs have been 
shown to play an important role in tumor autophagy, 
and affect the occurrence and growth of human cancer, 
according to new research. Furthermore, circ 104075 
was linked to glioma cell autophagy and apoptosis. In 
glioma U251 cells, circ 104075 overexpression neutralized 
Matrine’s inhibitory impact on proliferation and enhanced 
cell autophagy.44 Nonetheless, research on the importance 
of circRNAs in tumor autophagy is in its early stages, 
and the real role and function, as well as the possible 
mechanisms underlying this, must be investigated in the 
future.
CircRNAs Interact With RBPs and Act as a Protein 
Scaffold
CircRNAs may bind to specific proteins to make circRNPs 
(circRNA protein complexes), which then regulate 
the function of related proteins, protein subcellular 
localization, and the transcription of parental or related 
genes. CircRNAs are involved in multiple human 
diseases through various mechanisms.45 By functioning 
as a sponge, they may decrease the inhibitory impact of 
miRNAs on messenger RNA (mRNA).46,47 Furthermore, 
by serving as dynamic scaffolds, circRNAs interacts 
with RBPs and regulate their function.6,48 CicRNAs work 
as protein sponges, miRNA sponges, or scaffolds, and 
splicing activity regulators.23 CircRNA binds to RBPs and 
impairs their role. RBPs are a family of proteins that play a 
critical role in gene translation and transcription.49 RBPs 
could be sequestered, stored, and sorted by circRNA, 
Figure 2. The present diagram shows the regulatory relationship of circRNA-miRNA-mRNA networks with different signaling pathways 
that are involved in brain tumorigenesis. Several circRNAs have been shown to act as miRNA sponges, thereby regulating the expression 
level of downstream genes. These target genes or proteins, by acting as regulatory proteins or transcription factors and other mechanisms, 
regulate factors associated with tumor signaling pathways.
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allowing it to regulate their intracellular localization.50,51 
RBP quaking has been shown to modulate the circRNA 
shape by creating RNA-protein complexes (RPCs) in 
recent studies.52 Furthermore, RBM20 (RNA-binding 
motif protein 20) affected the development of a subset 
of circRNAs, forming the RBM20-dependent circRNAs 
class.53 As a result, circRNA and RPBs are strongly linked 
to the prevalence and progression of cancer. Overall, 
circRNAs influence cell migration, proliferation, growth, 
invasion, and other pathological processes and are 
expressed abnormally and linked to the human cancer 
emergence and progression. CircRNA also interacts with 
protein compared with RBPs. It may serve as protein 
sponges by adsorption of one or more proteins through 
their binding sites, mediating protein interaction directly 
by functioning as protein scaffolding, and thereby 
regulating the expression of gene. In tumors, CDK2 
(cyclin-dependent kinase 2) and p21 proteins, for example, 
are correlated to cell cycle control. CircFOXO3 can act 
as a scaffold for the development of the circFOXO3-
p21-CDK2 ternary complex, inhibiting CDK2 role and 
thereby influencing cancer cell cycle progression.54 
CircRNAs Play a Role in Gene Alternative Splicing, 
Translation, and Transcription Processes
The circRNA in the nucleus served as splicing or 
transcriptional controls, interfering with expression of 
gene and participating in alternative transcription and 
splicing. For instance, in tumor cells, circPOK that is 
originated from the zbtb7a gene affected the transcription 
of gene via encoding the Pokemon transcription 
factor, hence regulation of the pro-angiogenic and 
proproliferative factors by activation of ILF2/3 
(interleukin enhancer-binding factor 2 and 3) complex.55 
Furthermore, by inhibiting RREB1 (RAS-responsive 
element-binding protein 1) transcription factor through 
the Ras pathway, circITGA7 increased the transcription 
of its host itga7 (integrin Subunit alpha 7) gene.56 Gene 
transcription, alternative splicing, and translation are 
critical processes to exert biological functions in cancers, 
but circRNA highly influences these processes.
CircRNAs Can Be Translated Into Peptides That Are 
Related to Glioma
They have ORFs in their sequences, according to recent 
research.57-59 N6-methyladenosine (m6A)-mediated 
initiation or internal ribosome entry site (IRES)-driven 
may be used to translate circRNAs into proteins.60 
Several translatable circRNAs have been discovered in 
various tumors, including glioma. CircRNA-encoded 
peptides/proteins are normally fewer than 100 aa long 
and perform important roles EMT transition, in tumor 
energy metabolism, and the stabilization of the c-Myc 
oncoprotein. CircRNA and the peptides/proteins encoded 
by the circRNAs were essential in tumor cell invasion and 
progression. Nevertheless, peptides encoded by circRNAs 
were often found to be innately linked to glioma 
tumorigenesis, suggesting the pivotal role of circRNA in 
glioma malignant progressing. FBXW7-185aa is a 21-kDa 
protein encoded by circ-FBXW7. By reducing the half-
life of c-Myc and antagonizing USP28-induced c-Myc 
stabilization, up-regulation of FBXW7-185aa blocked 
proliferation and cell cycle acceleration. Furthermore, 
in GMB samples, FBXW7-185aa and circ-FBXW7 
were down-regulated, and circ-FBXW7 expression was 
correlated with GMB patient survival.61 CircLINC-PINT 
can encode a PINT87aa peptide. PINT87aa interacted 
with PAF1c (polymerase-associated factor 1 complex) 
directly and inhibited the transcriptional elongation of 
multiple oncogenes like c-Myc, SOX-2, and CPEB1.62 
Circ-SHPRH can be translated into17 kDa SHPRH-146aa 
peptide, which is associated with glioma. In human brains, 
SHPRH- 146aa and circ-SHPRH are strongly expressed, 
but in GMB, they are down-regulated. SHPRH-146aa 
prevented full-length SHPRH from being degraded 
through the ubiquitin-proteasome, resulting in cell 
proliferation inhibition.63 GBM progression was blocked 
by AKT3-174aa, which was translated by circ-AKT3 and 
interacted with phosphorylated PDK1 competitively.64 
Bagchi found that circ 12152, a protein originating from 
human chromosome 9: 87482157e87570432, played a role 
in GMB development.65
Association of circRNAs With Glioma/Glioblastoma
Abnormal expression of circRNAs has been linked to 
the formation of gliomas, according to mounting data. 
Song and colleagues looked at RNA-seq evidence from 
46 gliomas and non-cancerous brain samples and found 
thousands of circRNA members; 476 were expressed 
differentially.12 In one study, 1411 circRNAs were found to 
have different expressions in GBM patients. Of the 1411 
circRNAs, 1205 circRNAs were down-regulated and 206 
circRNAs were up-regulated; this suggests that circRNAs 
dysregulation is linked to the biological mechanism.66
Another research discovered that 2038 circRNAs were 
changed in GMB tissue compared to matched natural 
brain tissue. 36 circRNAs were up-regulated and 2002 
circRNAs were down-regulated among the differentially 
expressed circRNAs. Furthermore, the development of 
co-expression networks indicated that changed circRNAs, 
which were found to be enriched in several tumor-related 
pathways, served as neurological disorder drivers or 
brain tumors.67 In both oligodendroglioma and GMB, 
a circRNA originating from the VCAN gene, which 
has been linked to gliomagenesis, was shown to be up-
regulated.12 In glioma, circZNF292 was reported to be 
down-regulated,68 whereas a circRNA originating from 
the ttbk2 gene was found to be up-regulated.29 Finally, 
Barbagallo et al examined miR-671-5p expression in 
primary samples of GMB patient and GMB cell lines 
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and discovered that it was overexpressed and associated 
with ciRS-7 down-regulation.69 CircRNAs’ functional 
and identification studies indicate that they act as tumor 
suppressors or oncogenes that regulate downstream target 
genes (Table 1). 
CircRNAs Act as Oncogenes in Glioma/Glioblastoma 
Tumorigenesis
CircZNF292 is a significant circular oncogenic RNA that 
affects tube forming.68 In one study, it was shown that 
circZNF292 silencing inhibited cell proliferation and 
repressed cell cycle progression in the glioma through 
the Wnt/β-catenin signaling pathway. After circZNF292 
silencing, the expression levels of transcription factors 
STAT3, STAT5, AP-1, NF-κB, E2F1 and HIF-1 expression 
were significantly reduced, implying that circZNF292 may 
inhibit NF-κB and STAT3/5.68 In the U87MG and U251 
cell lines of human glioma, suppression of circZNF292 
represses glioma tube formation through the Wnt/β-
catenin signaling pathway associated genes like VEGF-A 
Table 1. Expression and Functional Role of circRNAs in Glioma/Glioblastoma
CircRNAs/Peptides
Type of Brain 
Tumor





CircZNF292 Glioma Oncogene Up-regulated
Progression of glioma tube formation, 
and promote glioma proliferation and 
cell cycle progression
Hsa_circ_0076248 Glioma Oncogene Up-regulated
Promote glioma proliferation and 
invasion
Circ_0034642 Glioma Oncogene Up-regulated
Promote glioma proliferation, invasion, 
and migration, and inhibit cell apoptosis
Circ_ 0046701 Glioma Oncogene Up-regulated Promote cell proliferation, and invasion
Circ-0012129 Glioma Oncogene Up-regulated Promote cell proliferation, and invasion
CircPTN Glioma Oncogene Up-regulated Promote glioma growth and stemness
Circ_0000177 Glioma Oncogene Up-regulated
Promote glioma proliferation and 
invasion
CircCPA4 Glioma Oncogene Up-regulated
Regulate the proliferation and metastasis 
of glioma
CircSCAF11 Glioma Oncogene Up-regulated Accelerate the glioma tumorigenesis
Circ- TTBK2 Glioma Oncogene Up-regulated
Promote proliferation and inhibited 
apoptosis
Hsa-circ-0014359 Glioma Oncogene Up-regulated Promote glioma progression
Circ‐U2AF1 Glioma Oncogene Up-regulated Promote glioma malignancy
Circ-CFH Glioma Oncogene Up-regulated Promote glioma proliferation
CircNFIX Glioma Oncogene Up-regulated Enhance glioma progression
Circ-SHKBP1 Glioma Oncogene Up-regulated Regulate glioma angiogenesis
Circ_002136 Glioma Oncogene Up-regulated
Promote the progression of glioma and 
Regulate angiogenesis
Circ-DICER1 Glioma Oncogene Up-regulated Regulate angiogenesis in glioma
CircHIPK3 Glioma Oncogene Up-regulated
Regulate cell growth and promote glioma 
progression
Circ-PITX1 Glioblastoma Oncogene Up-regulated Promote the progression of glioblastoma
CircNT5E Glioblastoma Oncogene Up-regulated
Promote proliferation, invasion, and 
migration of cancer cells
Circ_0029426 Glioblastoma Oncogene Up-regulated
promote cell proliferation, migration 
and invasion, inhibited cell apoptosis of 
Glioblastoma
Circ-ITCH Glioma Tumor suppressor Down-regulated
Suppress cell proliferation, and promote 
cell apoptosis
Hsa_circ_0001649 Glioma Tumor suppressor Down-regulated
Inhibit cell growth, and facilitate 
apoptosis
FBXW7-185aa encoded by 
circ-FBXW7
Glioma Tumor suppressor Down-regulated Repress glioma
SHPRH-146aa encoded by 
circRNA SHPRH
Glioma Tumor suppressor Down-regulated Reduce tumorigenicity
CircMTO1 Glioblastoma Tumor suppressor Down-regulated Inhibit glioblastoma proliferation
Circ_0001946 Glioblastoma Tumor suppressor Down-regulated
Inhibits cell proliferation, migration, 
invasion and induced apoptosis in 
glioblastoma cells
CircSMARCA5 Glioblastoma Tumor suppressor Down-regulated Anti-angiogenic function
Circ-SHPRH Glioblastoma Tumor suppressor Down-regulated
Suppress tumor progression and 
tumorigenesis
AKT3-174aa encoded by 
circ-AKT3
Glioblastoma Tumor suppressor Down-regulated Inhibit Glioblastoma progression
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and EGFR genes, and the VEGF-A receptor VEGFR-1/2.68 
Hsa_circ_0076248 and circ_0034642 were found to 
facilitate glioma invasion and proliferation in miR-181a/
SIRT1 and the miR-1205/BATF3 axis, respectively.33,34 It 
has been discovered that hsa_circ_0076248 facilitates 
glioma oncogenesis. The hsa_circ_0076248 could be a 
sponge for miR181a, and miR181a could be a target for 
SIRT1 mRNA. Down-regulation of hsa_circ_0076248 or 
up-regulation of miR‐181a could depress the invasion 
and proliferation of glioma in vivo and in vitro.33 It 
has been shown that, in tissues and cell lines of glioma 
circ_0034642 was up-regulated. In glioma patients, 
overexpression of circ_0034642 was linked to negative 
phenotypes. Circ_0034642 has the ability to facilitate cell 
invasion, proliferation, and migration, while preventing 
cell apoptosis. Circ_0034642 was discovered to be a miR-
1205 sponge, and miR-1205 has been shown to regulate 
BATF3 expression by targeting the 3′ UTR of BATF3. 
Circ_0034642’s oncogenic function is attributed partly 
to its modulation of the miR-1205/BATF3 axis. The 
circ_0034642 /miR-1205/BATF3 pathway, taken together, 
can play a key role in glioma.34 Li and colleagues found 
that in glioma cell lines and tissues circ_0046701 was 
significantly up-regulated, and that knocking it down 
significantly reduced cell invasion and proliferation by up-
regulating miR-142-3p, which led to down-regulation of 
ITGB8.70 Circ-0012129 was also shown to be substantially 
augmented in glioma tissues, and its knockdown reduced 
the invasion and proliferation capabilities of SHG44 and 
U373 glioma lines significantly by up-regulating miR-661 
expression.71 CircPTN improved Nestin, SOX9, CD133, 
and SOX2 expression and facilitated glioma development 
and stemness by sponging miR-330-5p and miR-145-5p.32 
Chen et al found that in cell lines of glioma circ_0000177 
was up-regulated, and that its overexpression stimulated 
invasion and proliferation by FZD7-induced Wnt pathway 
activation via miR-638 sponging.72 CircCPA4 and 
circSCAF11 were substantially up-regulated in glioma73,74; 
they accelerated glioma tumorigenesis through let7/
CPA4 and miR421/SP1/VEGFA, respectively. According 
to Zheng’s research, circ-TTBK2 acted as a miR-217 
sponge, promoting proliferation and inhibiting apoptosis 
in a sequence-specific manner. Furthermore, HNF1 was 
a direct miR-217 target and triggered Derlin-1 through 
ERK and PI3K/AKT signaling pathways by binding to its 
promoter, implying that blocking the circ-TTBK2/miR-
217/HNF1/Derlin-1 axis may be a possible treatment 
aim for human gliomas.29,75,76 MiR-153 facilitated glioma 
progression through the PI3K/AKT/mTOR signaling 
cascade, which was activated by circ-0014359.77 Li et al 
found that circ-U2AF1 stimulated glioma tumorigenesis 
through repressing neurooncological ventral antigen 2 
(NOVA2) by sponging has-miR-7-5p.78 Circ-CFH was 
substantially up-regulated in glioma tissue and positively 
associated with tumor grade, and it significantly improved 
glioma cell proliferative capacity by releasing AKT1 
and sponging miR-149.79 Xu and colleagues found that 
circNFIX increased development of glioma via sponging 
miR-34a-5p and up-regulating the target gene NOTCH1 
through the Notch signaling pathway.80 Other researchers 
found that circ-SHKBP1 was up-regulated in glioma 
exposed endothelial cells (GECs) and glioma microvessels, 
and that it inhibited FOXP1/FOXP2 expression via 
targeting miR-544a/miR-379. As a result of targeting the 
miR-379/FOXP2/AGGF1 and miR-544a/FOXP1/AGGF1 
pathways, circ-SHKBP1 modulated glioma angiogenesis.81 
FUS, a member of the FET (FUS/EWS/TAF15) protein 
family, can regulate circ_002136 expression by binding 
to introns flanking the splicing site. Circ_002136 or 
FUS inhibition significantly reduced tube generation in 
U87 GECs. The FUS/circ 002136/miR-138-5p/SOX13 
feedback loop has been shown to regulate angiogenesis 
in glioma.82,83 Another study found that MOV10 binding 
circ-DICER1 inhibited glioma angiogenesis in GECs 
by negatively regulating miR-103a-3p/miR-382-5p on 
ZIC4.By triggering the PI3K/Akt pathway, ZIC4 could 
upregulate downstream target Hsp90 that promotes 
tube forming in GECs.84 CircRNAHIPK3 may sponge 
many miRNAs, like miR-124-3p and miR-654.30 miR-654 
was indicated as a circHIPK3 target; however, miR-654 
targeted IGF2BP3, circHIPK3 induced progression of 
glioma by the circHIPK3/miR-654/IGF2BP3 network.31 
The circ-HIPK3 overexpression increased the invasive 
and proliferative abilities of glioma cells through sponging 
miR-124-3p, which increased the amount of STAT3.85 
To regulate the miR-379–5p/MAP3K2 axis, Circ-PITX1 
was dramatically up-regulated in GBM and facilitated 
GBM progression by a competing endogenous RNA.86 
CircNT5E aided GMB tumorigenesis via functioning as a 
miR-422a sponge.38 Circ_0029426 by sponging miR-197, 
causing proliferation, invasion, and migration while also 
inhibiting GBM cell apoptosis.36
CircRNAs Act as Tumor Suppressors in Glioma/
Glioblastoma
Cir-ITCH was shown to be down-regulated in cell 
lines and tissues of glioma. Overexpression of cir-
ITCH substantially stopped cell proliferation. Similarly, 
increased cir-ITCH expression reduced the number 
of established colonies while increasing the number 
of apoptotic cells. Cir-ITCH inhibited glioma cells’ 
capacity to repair wounds dramatically. Glioma cells’ 
invasive and migratory capacities were significantly 
reduced when cir-ITCH was up-regulated. Cir-ITCH 
inhibits tumor progression in glioma cells in a number 
of studies.87 Cir-ITCH has been shown to have an anti-
oncogenic function by regulating the ITCH-Wnt/-
catenin pathway and sponging miR-214.87 In another 
research, hsa_circ_0001649 was shown to be reduced in 
glioma tissues and cell lines. Hsa_circ_0001649 that was 
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down-regulated was associated to a greater tumor scale. 
In vivo and in vitro, hsa_circ_0001649 overexpression 
prevented cell development. Furthermore, up-regulated 
hsa_circ_0001649 aided apoptosis by regulation of the 
Bcl-2/caspase-3 pathway.88 CircumMTO1 expression 
was shown to be significantly reduced in GBM tissues. 
circMTO1 inhibits GBM cell proliferation through the 
miR-92/WWOX signaling pathway, according to Zhang 
et al., CircMTO1 interacts specifically with miR-92 and 
then functions as a miRNA sponge to increase WWOX 
expression.89 Circ_0001946 was found to be down-
regulated in GBM cells, and circ_0001946 overexpression 
blocked cell proliferation, invasion, triggered apoptosis, 
and migration in GBM cells by up-regulation of the 
expression of CDR1(cerebellar degeneration-related 
auto-antigen 1) and inhibiting miR-671-5p expression 
in GBM cells. The circ_0001946/miR671-5p/ CDR1 
pathway has been shown to influence the progression 
of GBM.90 According to a recent review, circSMARCA5 
serves as a sponge for the splicing factor SRSF1 (serine 
and arginine rich splicing factor 1), which targets and 
mediates VEGFA expression in GBM and hence has anti-
angiogenic properties.37 An FBXW7-185aa, translated 
from circ-FBXW7, suppressed glioma disruptive activities 
by antagonizing USP28-induced c-Myc stabilization.61 
SHPRH-146aa, translated from the circ-SHPRH, was 
shown to be plentiful in typical human brains but 
depleted in glioma. It also decreases tumorigenicity 
by preserving full-length SHPRH, which acts as an E3 
ligase to ubiquitinate PCNA. Both of them have a tumor 
suppressant function in glioma.61,63 Furthermore, AKT3-
174aa, a tumor suppressor protein encoded by circ-
AKT3, prevented GBM development by interacting with 
phosphorylated PDK1.64
The role of circRNAs in Alzheimer’s and Parkinson’s 
Diseases
CircRNAs affect so many nervous system disorders, 
like Alzheimer’s, and is caused by ciRS-7 sponging miR-
7.91 CDR1as/ciRS-7 is significantly miss-regulated in 
Alzheimer’s disease patients’ hippocampal CA1 area.92 
CircRNAs, particularly CDR1as/ciRS-7, the best-
characterized and most widely expressed mammalian 
circRNA,39 have been linked to brain degeneration and 
illness in several studies. CDR1as/ciRS-7 in humans 
contains 74 miR-7 binding sites and is aligned with the 
Argonaute protein in a miR-7-dependent manner.39,45 
MiR-7 has been linked to neurological disorders such as 
Parkinson’s disease. Several reports have suggested that 
miR-7 plays a neuroprotective function in dopaminergic 
neurons. MiR-7 may target the Parkinson disease-related 
α-synuclein protein and is active in up-regulating the 
mTOR pathway to defend neurons from cell death caused 
by the dopaminergic neurotoxic compound 1-methyl-4-
phenylpyridinium (MPP (+)).93,94 The circRNAs’ sponge 
function, especially CDR1as/ciRS-7, could thus affect the 
progression and onset of Parkinson’s disease.
Future Directions and Conclusion
Extensive studies have led to our deep understanding of the 
impact of complex circRNAs network in the incidence of 
glioma/GMB and have presented preliminary information 
about their role in the progression and initiation of brain 
tumors. Certain circRNAs are involved in some brain 
tumor diseases. circRNAs act as tumor suppressors or 
oncogenes which govern downstream target genes with 
notable clinical usages. Cir-ITCH, for example, is a tumor 
inhibitor in glioma and may be a promising predictor as 
a biomarker for glioma patients. Therefore, controlling 
the increase in cir-ITCH expression could be the future 
direction for developing a new therapeutic strategy. We 
believe that further recognition of regulatory functions 
of circRNAs in carcinogenic signaling pathways and 
greater understanding of future glioma/GBM molecular 
biology can help to use circRNAs as prognostic and 
diagnostic biomarkers and establish an application in 
new therapeutic targets. Identification of biomarkers 
with high specificity and sensitivity in the diagnosis of 
brain tumors, identifying people at high risk, developing 
targeted therapies, and evaluating the response to 
treatment are extensively used by many clinical experts. 
Although the identification of a number of circRNAs 
with known functions is on the rise, circRNAs research 
is still in its infancy, and there are still thousands of types 
of circRNAs with unknown functions. Most circRNAs 
may have a known single function or may together create 
a single role. It is also possible that a large fraction of the 
circRNAs expressed do not function specifically and are 
only byproducts of trimming. Therefore, knockouting 
circRNAs with specific genomic editing tools may help 
to know their performance. With advances in molecular 
biotechnology and full understanding of the functions of 
circRNAs, successful and safe circRNAs-based therapeutic 
strategies are hoped to be achieved in the not too distant 
future.
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